Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage plasmodium berghei parasites

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Gerald, Noel J ^a   Majam, Victoria ^a   Mahajan, Babita ^a   Kozakai, Yukiko ^a   Kumar, Sanjai ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; CESIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; BLOOD SMEAR; BRAIN MALARIA; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; EXTRACELLULAR MATRIX; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PARASITE VIRULENCE; PARASITEMIA; PLASMODIUM BERGHEI; RADIATION ATTENUATION; RADIATION DOSE; RADIATION EXPOSURE; SPLEEN WEIGHT; ANIMAL; C57BL MOUSE; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; MALARIA; METABOLISM; PARASITOLOGY; PHYSIOLOGY;

MURINAE; MUS; PLASMODIUM BERGHEI;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CESIUM RADIOISOTOPES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INTERFERON-GAMMA; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; PARASITEMIA; PLASMODIUM BERGHEI;

EID: 80052841289     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024398     Document Type: Article

References (37)

1. Pinzon-Charry A, Good MF, (2008) Malaria vaccines: the case for a whole-organism approach. Expert Opin Biol Ther 8: 441-448.
2. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, et al. (2010) Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Human Vaccines 6: 97-106.
3. Mikolajczak SA, Aly AS, Kappe SH, (2007) Preerythrocytic malaria vaccine development. Curr Opin Infect Dis 20: 461-466.
4. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, et al. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185: 1155-1164.
5. Vanderberg JP, (2009) Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond. Vaccine 27: 2-9.
6. Purcell LA, Wong KA, Yanow SK, Lee M, Spithill TW, et al. (2008) Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine 26: 4880-4884.
7. Belnoue E, Costa FT, Frankenberg T, Vigario AM, Voza T, et al. (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172: 2487-2495.
8. Mueller AK, Labaied M, Kappe SH, Matuschewski K, (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433: 164-167.
9. Vaughan AM, Wang RB, Kappe SHI, (2010) Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Human Vaccines 6: 107-113.
10. VanBuskirk KM, O'Neill MT, De La Vega P, Maier AG, Krzych U, et al. (2009) Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A 106: 13004-13009.
11. Good MF, (2009) The hope but challenge for developing a vaccine that might control malaria. Eur J Immunol 39: 939-943.
12. Sadun EH, Wellde BT, Hickman RL, (1969) Resistance produced in owl monkeys (Aotus trivirgatus) by inoculation with irradiated Plasmodium falciparum. Mil Med 134: 1165-1175.
13. Wellde BT, Sadun EH, (1967) Resistance produced in rats and mice by exposure to irradiated Plasmodium berghei. Exp Parasitol 21: 310-324.
14. Spaccapelo R, Janse CJ, Caterbi S, Franke-Fayard B, Bonilla JA, et al. (2010) Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria. Am J Pathol 176: 205-217.
15. Ting LM, Gissot M, Coppi A, Sinnis P, Kim K, (2008) Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. Nat Med 14: 954-958.
16. Aly AS, Downie MJ, Mamoun CB, Kappe SH, (2010) Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Cell Microbiol.
17. Belnoue E, Voza T, Costa FT, Gruner AC, Mauduit M, et al. (2008) Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol 181: 8552-8558.
18. Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, et al. (2002) Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360: 610-617.
19. Engwerda C, Belnoue E, Gruner AC, Renia L, (2005) Experimental models of cerebral malaria. Curr Top Microbiol Immunol 297: 103-143.
20. Oakley MS, Majam V, Mahajan B, Gerald N, Anantharaman V, et al. (2009) Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice. PLoS ONE 4: e6793.
21. Pais TF, Chatterjee S, (2005) Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation. J Neuroimmunol 163: 73-83.
22. Mahajan B, Berzofsky JA, Boykins RA, Majam V, Zheng H, et al. (2010) Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infect Immun 78: 4613-4624.
23. Curfs JH, Hermsen CC, Meuwissen JH, Eling WM, (1992) Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology 105 (Pt 1): 7-14.
24. McCarthy JS, Good MF, (2010) Whole parasite blood stage malaria vaccines: A convergence of evidence. Hum Vaccin 6.
25. Hughes HP, Dixon B, (1980) Vaccination of chicks against Plasmodium gallinaceum by erythrocytic and exoerythrocytic parasites attenuated by gamma irradiation. Ann Trop Med Parasitol 74: 115-126.
26. Wellde BT, Diggs CL, Anderson S, (1979) Immunization of Aotus trivirgatus against Plasmodium falciparum with irradiated blood forms. Bull World Health Organ 57 (Suppl 1): 153-157.
27. Hansen DS, Bernard NJ, Nie CQ, Schofield L, (2007) NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J Immunol 178: 5779-5788.
28. Augustine AD, Hall BF, Leitner WW, Mo AX, Wali TM, et al. (2009) NIAID workshop on immunity to malaria: addressing immunological challenges. Nat Immunol 10: 673-678.
29. Doolan DL, Dobano C, Baird JK, (2009) Acquired immunity to malaria. Clin Microbiol Rev 22: 13-36, Table of Contents.
30. Langhorne J, Ndungu FM, Sponaas AM, Marsh K, (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732.
31. Schofield L, (2007) Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunol Cell Biol 85: 130-137.
32. Mitchell AJ, Hansen AM, Hee L, Ball HJ, Potter SM, et al. (2005) Early cytokine production is associated with protection from murine cerebral malaria. Infect Immun 73: 5645-5653.
33. Elliott SR, Kuns RD, Good MF, (2005) Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. Infect Immun 73: 2478-2485.
34. Baptista FG, Pamplona A, Pena AC, Mota MM, Pied S, et al. (2010) Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect Immun 78: 4033-4039.
35. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, et al. (2003) Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 170: 2221-2228.
36. Amante FH, Haque A, Stanley AC, Rivera Fde L, Randall LM, et al. (2010) Immune-Mediated Mechanisms of Parasite Tissue Sequestration during Experimental Cerebral Malaria. J Immunol 185: 3632-3642.
37. Claser C, Malleret B, Gun SY, Wong AY, Chang ZW, et al. (2011) CD8+ T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS ONE 6: e18720.